Related Experiment Videos

Clinical isolates of measles virus use CD46 as a cellular receptor

M Manchester1, D S Eto, A Valsamakis

  • 1Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California 92037, USA. marim@scripps.edu

Journal of Virology
|February 7, 2001
PubMed

Insights

Measles virus (MV) clinical isolates primarily use CD46 as a receptor, though cell type influences tropism. Adaptation to cell culture can alter MV receptor usage, highlighting CD46

Area of Science:

  • Virology
  • Immunology

Background:

  • Laboratory measles virus (MV) strains utilize CD46 as a cellular receptor.
  • Receptor usage by clinical MV isolates is not well-understood.

Purpose of the Study:

  • To investigate the cell surface receptor usage of primary measles virus patient isolates.
  • To compare receptor usage between MV isolates adapted to cell culture and those directly from patients.

Main Methods:

  • Primary MV patient isolates were analyzed for receptor usage.
  • Isolates were passaged on various tissue culture cell lines to assess adaptation.
  • Tropism was evaluated across different cell types, including lymphocytes and fibroblasts.

Main Results:

  • All MV isolates demonstrated CD46-dependent infection.
  • Cell type significantly restricted MV tropism.
  • Unadapted patient isolates consistently used CD46.
  • Passaging in B95-8 cells selected for altered receptor usage.

Conclusions:

  • Primary measles virus isolates utilize CD46 as their cellular receptor.
  • Measles virus tropism is cell-type dependent and influenced by adaptation to cell culture.
  • CD46 is confirmed as a relevant receptor for natural measles virus infection.

Related Concept Videos